| Onyx Biotec Ltd | Industry : Pharmaceuticals | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | ||
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 18.13 | 13.32 | 5.90 | 5.90 | |
| Reserves | 37.49 | 11.97 | 12.30 | 10.47 | |
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | |
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Shareholders Funds | 55.62 | 25.29 | 18.20 | 16.37 | |
| Secured Loans | 11.19 | 28.31 | 26.63 | 11.26 | |
| Unsecured Loans | 1.27 | 2.47 | 2.60 | 0.99 | |
| Total Debt | 12.46 | 30.78 | 29.23 | 12.25 | |
| Other Liabilities | 0.00 | 0.00 | 0.44 | 0.38 | |
| Total Liabilities | 68.08 | 56.07 | 47.87 | 29.00 | |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 40.90 | 60.14 | 56.92 | 30.33 | |
| Less: Accumulated Depreciation | 0.00 | 16.66 | 14.41 | 13.09 | |
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Block | 40.90 | 43.48 | 42.51 | 17.24 | |
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work in Progress | 0.00 | 0.00 | 0.00 | 4.02 | |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Current Assets, Loans & Advances | |||||
| Inventories | 16.10 | 9.10 | 6.33 | 3.05 | |
| Sundry Debtors | 20.23 | 15.37 | 5.08 | 8.42 | |
| Cash and Bank Balance | 8.61 | 1.47 | 0.01 | 0.01 | |
| Loans and Advances | 4.24 | 3.62 | 3.16 | 2.95 | |
| Total Current Assets | 49.19 | 29.56 | 14.57 | 14.43 | |
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 19.03 | 15.08 | 8.94 | 6.37 | |
| Provisions | 1.00 | 0.27 | 0.06 | 0.05 | |
| Total CL & Provisions | 20.03 | 15.36 | 8.99 | 6.42 | |
| Net Current Assets | 29.16 | 14.20 | 5.58 | 8.01 | |
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets | 0.00 | 0.00 | 0.12 | 0.11 | |
| Deferred Tax Liability | 3.14 | 2.71 | 1.99 | 1.53 | |
| Net Deferred Tax | -3.14 | -2.71 | -1.87 | -1.42 | |
| Other Assets | 1.16 | 1.10 | 1.66 | 1.15 | |
| Total Assets | 68.08 | 56.07 | 47.87 | 29.00 | |
| Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |